Global Sickle Cell Anemia Therapeutics Market Insights, Forecast to 2029

Global Sickle Cell Anemia Therapeutics Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Blood Transfusion
1.2.3 Pharmacotherapy
1.2.4 Bone Marrow Transplant
1.3 Market by Application
1.3.1 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Child
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Anemia Therapeutics Market Perspective (2018-2029)
2.2 Global Sickle Cell Anemia Therapeutics Growth Trends by Region
2.2.1 Sickle Cell Anemia Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Sickle Cell Anemia Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Sickle Cell Anemia Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Sickle Cell Anemia Therapeutics Market Dynamics
2.3.1 Sickle Cell Anemia Therapeutics Industry Trends
2.3.2 Sickle Cell Anemia Therapeutics Market Drivers
2.3.3 Sickle Cell Anemia Therapeutics Market Challenges
2.3.4 Sickle Cell Anemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Sickle Cell Anemia Therapeutics by Players
3.1.1 Global Sickle Cell Anemia Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Sickle Cell Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Sickle Cell Anemia Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio
3.4.1 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Anemia Therapeutics Revenue in 2022
3.5 Global Key Players of Sickle Cell Anemia Therapeutics Head office and Area Served
3.6 Global Key Players of Sickle Cell Anemia Therapeutics, Product and Application
3.7 Global Key Players of Sickle Cell Anemia Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Anemia Therapeutics Breakdown Data by Type
4.1 Global Sickle Cell Anemia Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Type (2024-2029)
5 Sickle Cell Anemia Therapeutics Breakdown Data by Application
5.1 Global Sickle Cell Anemia Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Sickle Cell Anemia Therapeutics Market Size (2018-2029)
6.2 North America Sickle Cell Anemia Therapeutics Market Size by Type
6.2.1 North America Sickle Cell Anemia Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Sickle Cell Anemia Therapeutics Market Size by Type (2024-2029)
6.2.3 North America Sickle Cell Anemia Therapeutics Market Share by Type (2018-2029)
6.3 North America Sickle Cell Anemia Therapeutics Market Size by Application
6.3.1 North America Sickle Cell Anemia Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Sickle Cell Anemia Therapeutics Market Size by Application (2024-2029)
6.3.3 North America Sickle Cell Anemia Therapeutics Market Share by Application (2018-2029)
6.4 North America Sickle Cell Anemia Therapeutics Market Size by Country
6.4.1 North America Sickle Cell Anemia Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Sickle Cell Anemia Therapeutics Market Size (2018-2029)
7.2 Europe Sickle Cell Anemia Therapeutics Market Size by Type
7.2.1 Europe Sickle Cell Anemia Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Sickle Cell Anemia Therapeutics Market Size by Type (2024-2029)
7.2.3 Europe Sickle Cell Anemia Therapeutics Market Share by Type (2018-2029)
7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Application
7.3.1 Europe Sickle Cell Anemia Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Sickle Cell Anemia Therapeutics Market Size by Application (2024-2029)
7.3.3 Europe Sickle Cell Anemia Therapeutics Market Share by Application (2018-2029)
7.4 Europe Sickle Cell Anemia Therapeutics Market Size by Country
7.4.1 Europe Sickle Cell Anemia Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Sickle Cell Anemia Therapeutics Market Size (2018-2029)
8.2 China Sickle Cell Anemia Therapeutics Market Size by Type
8.2.1 China Sickle Cell Anemia Therapeutics Market Size by Type (2018-2023)
8.2.2 China Sickle Cell Anemia Therapeutics Market Size by Type (2024-2029)
8.2.3 China Sickle Cell Anemia Therapeutics Market Share by Type (2018-2029)
8.3 China Sickle Cell Anemia Therapeutics Market Size by Application
8.3.1 China Sickle Cell Anemia Therapeutics Market Size by Application (2018-2023)
8.3.2 China Sickle Cell Anemia Therapeutics Market Size by Application (2024-2029)
8.3.3 China Sickle Cell Anemia Therapeutics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Sickle Cell Anemia Therapeutics Market Size (2018-2029)
9.2 Asia Sickle Cell Anemia Therapeutics Market Size by Type
9.2.1 Asia Sickle Cell Anemia Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Sickle Cell Anemia Therapeutics Market Size by Type (2024-2029)
9.2.3 Asia Sickle Cell Anemia Therapeutics Market Share by Type (2018-2029)
9.3 Asia Sickle Cell Anemia Therapeutics Market Size by Application
9.3.1 Asia Sickle Cell Anemia Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Sickle Cell Anemia Therapeutics Market Size by Application (2024-2029)
9.3.3 Asia Sickle Cell Anemia Therapeutics Market Share by Application (2018-2029)
9.4 Asia Sickle Cell Anemia Therapeutics Market Size by Region
9.4.1 Asia Sickle Cell Anemia Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Sickle Cell Anemia Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Sickle Cell Anemia Therapeutics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Details
11.1.2 Emmaus Medical Business Overview
11.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Introduction
11.1.4 Emmaus Medical Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.1.5 Emmaus Medical Recent Developments
11.2 Addmedica
11.2.1 Addmedica Company Details
11.2.2 Addmedica Business Overview
11.2.3 Addmedica Sickle Cell Anemia Therapeutics Introduction
11.2.4 Addmedica Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.2.5 Addmedica Recent Developments
11.3 Gamida Cell
11.3.1 Gamida Cell Company Details
11.3.2 Gamida Cell Business Overview
11.3.3 Gamida Cell Sickle Cell Anemia Therapeutics Introduction
11.3.4 Gamida Cell Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.3.5 Gamida Cell Recent Developments
11.4 GlycoMimetics
11.4.1 GlycoMimetics Company Details
11.4.2 GlycoMimetics Business Overview
11.4.3 GlycoMimetics Sickle Cell Anemia Therapeutics Introduction
11.4.4 GlycoMimetics Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.4.5 GlycoMimetics Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Sickle Cell Anemia Therapeutics Introduction
11.5.4 Pfizer Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.5.5 Pfizer Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Sickle Cell Anemia Therapeutics Introduction
11.6.4 Novartis Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.6.5 Novartis Recent Developments
11.7 Global Blood Therapeutics
11.7.1 Global Blood Therapeutics Company Details
11.7.2 Global Blood Therapeutics Business Overview
11.7.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Introduction
11.7.4 Global Blood Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.7.5 Global Blood Therapeutics Recent Developments
11.8 Micelle BioPharma
11.8.1 Micelle BioPharma Company Details
11.8.2 Micelle BioPharma Business Overview
11.8.3 Micelle BioPharma Sickle Cell Anemia Therapeutics Introduction
11.8.4 Micelle BioPharma Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.8.5 Micelle BioPharma Recent Developments
11.9 Bluebird Bio
11.9.1 Bluebird Bio Company Details
11.9.2 Bluebird Bio Business Overview
11.9.3 Bluebird Bio Sickle Cell Anemia Therapeutics Introduction
11.9.4 Bluebird Bio Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.9.5 Bluebird Bio Recent Developments
11.10 Prolong Pharmaceuticals
11.10.1 Prolong Pharmaceuticals Company Details
11.10.2 Prolong Pharmaceuticals Business Overview
11.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Introduction
11.10.4 Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.10.5 Prolong Pharmaceuticals Recent Developments
11.11 Modus Therapeutics
11.11.1 Modus Therapeutics Company Details
11.11.2 Modus Therapeutics Business Overview
11.11.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Introduction
11.11.4 Modus Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.11.5 Modus Therapeutics Recent Developments
11.12 Sangamo Biosciences
11.12.1 Sangamo Biosciences Company Details
11.12.2 Sangamo Biosciences Business Overview
11.12.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Introduction
11.12.4 Sangamo Biosciences Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.12.5 Sangamo Biosciences Recent Developments
11.13 Bioverativ
11.13.1 Bioverativ Company Details
11.13.2 Bioverativ Business Overview
11.13.3 Bioverativ Sickle Cell Anemia Therapeutics Introduction
11.13.4 Bioverativ Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.13.5 Bioverativ Recent Developments
11.14 Imara
11.14.1 Imara Company Details
11.14.2 Imara Business Overview
11.14.3 Imara Sickle Cell Anemia Therapeutics Introduction
11.14.4 Imara Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.14.5 Imara Recent Developments
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Details
11.15.2 Ironwood Pharmaceuticals Business Overview
11.15.3 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Introduction
11.15.4 Ironwood Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023)
11.15.5 Ironwood Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Pharmacotherapy
Table 4. Key Players of Bone Marrow Transplant
Table 5. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Sickle Cell Anemia Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Sickle Cell Anemia Therapeutics Market Share by Region (2018-2023)
Table 9. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Sickle Cell Anemia Therapeutics Market Share by Region (2024-2029)
Table 11. Sickle Cell Anemia Therapeutics Market Trends
Table 12. Sickle Cell Anemia Therapeutics Market Drivers
Table 13. Sickle Cell Anemia Therapeutics Market Challenges
Table 14. Sickle Cell Anemia Therapeutics Market Restraints
Table 15. Global Sickle Cell Anemia Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Sickle Cell Anemia Therapeutics Revenue Share by Players (2018-2023)
Table 17. Global Top Sickle Cell Anemia Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Anemia Therapeutics as of 2022)
Table 18. Global Sickle Cell Anemia Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Sickle Cell Anemia Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Sickle Cell Anemia Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Sickle Cell Anemia Therapeutics, Product and Application
Table 22. Global Key Players of Sickle Cell Anemia Therapeutics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sickle Cell Anemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type (2024-2029)
Table 28. Global Sickle Cell Anemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Sickle Cell Anemia Therapeutics Revenue Share by Application (2018-2023)
Table 30. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Sickle Cell Anemia Therapeutics Revenue Share by Application (2024-2029)
Table 32. North America Sickle Cell Anemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Sickle Cell Anemia Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Sickle Cell Anemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Sickle Cell Anemia Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Sickle Cell Anemia Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Sickle Cell Anemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Sickle Cell Anemia Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Sickle Cell Anemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Sickle Cell Anemia Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Sickle Cell Anemia Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Sickle Cell Anemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Sickle Cell Anemia Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Sickle Cell Anemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Sickle Cell Anemia Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Sickle Cell Anemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Sickle Cell Anemia Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Sickle Cell Anemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Sickle Cell Anemia Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Sickle Cell Anemia Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Sickle Cell Anemia Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Sickle Cell Anemia Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 64. Emmaus Medical Company Details
Table 65. Emmaus Medical Business Overview
Table 66. Emmaus Medical Sickle Cell Anemia Therapeutics Product
Table 67. Emmaus Medical Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 68. Emmaus Medical Recent Developments
Table 69. Addmedica Company Details
Table 70. Addmedica Business Overview
Table 71. Addmedica Sickle Cell Anemia Therapeutics Product
Table 72. Addmedica Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 73. Addmedica Recent Developments
Table 74. Gamida Cell Company Details
Table 75. Gamida Cell Business Overview
Table 76. Gamida Cell Sickle Cell Anemia Therapeutics Product
Table 77. Gamida Cell Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 78. Gamida Cell Recent Developments
Table 79. GlycoMimetics Company Details
Table 80. GlycoMimetics Business Overview
Table 81. GlycoMimetics Sickle Cell Anemia Therapeutics Product
Table 82. GlycoMimetics Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 83. GlycoMimetics Recent Developments
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Sickle Cell Anemia Therapeutics Product
Table 87. Pfizer Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 88. Pfizer Recent Developments
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Sickle Cell Anemia Therapeutics Product
Table 92. Novartis Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 93. Novartis Recent Developments
Table 94. Global Blood Therapeutics Company Details
Table 95. Global Blood Therapeutics Business Overview
Table 96. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product
Table 97. Global Blood Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 98. Global Blood Therapeutics Recent Developments
Table 99. Micelle BioPharma Company Details
Table 100. Micelle BioPharma Business Overview
Table 101. Micelle BioPharma Sickle Cell Anemia Therapeutics Product
Table 102. Micelle BioPharma Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 103. Micelle BioPharma Recent Developments
Table 104. Bluebird Bio Company Details
Table 105. Bluebird Bio Business Overview
Table 106. Bluebird Bio Sickle Cell Anemia Therapeutics Product
Table 107. Bluebird Bio Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 108. Bluebird Bio Recent Developments
Table 109. Prolong Pharmaceuticals Company Details
Table 110. Prolong Pharmaceuticals Business Overview
Table 111. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product
Table 112. Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 113. Prolong Pharmaceuticals Recent Developments
Table 114. Modus Therapeutics Company Details
Table 115. Modus Therapeutics Business Overview
Table 116. Modus Therapeutics Sickle Cell Anemia Therapeutics Product
Table 117. Modus Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 118. Modus Therapeutics Recent Developments
Table 119. Sangamo Biosciences Company Details
Table 120. Sangamo Biosciences Business Overview
Table 121. Sangamo Biosciences Sickle Cell Anemia Therapeutics Product
Table 122. Sangamo Biosciences Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 123. Sangamo Biosciences Recent Developments
Table 124. Bioverativ Company Details
Table 125. Bioverativ Business Overview
Table 126. Bioverativ Sickle Cell Anemia Therapeutics Product
Table 127. Bioverativ Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 128. Bioverativ Recent Developments
Table 129. Imara Company Details
Table 130. Imara Business Overview
Table 131. Imara Sickle Cell Anemia Therapeutics Product
Table 132. Imara Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 133. Imara Recent Developments
Table 134. Ironwood Pharmaceuticals Company Details
Table 135. Ironwood Pharmaceuticals Business Overview
Table 136. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product
Table 137. Ironwood Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 138. Ironwood Pharmaceuticals Recent Developments
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Sickle Cell Anemia Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Blood Transfusion Features
Figure 4. Pharmacotherapy Features
Figure 5. Bone Marrow Transplant Features
Figure 6. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Sickle Cell Anemia Therapeutics Market Share by Application: 2022 VS 2029
Figure 8. Child Case Studies
Figure 9. Adult Case Studies
Figure 10. Sickle Cell Anemia Therapeutics Report Years Considered
Figure 11. Global Sickle Cell Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Sickle Cell Anemia Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Sickle Cell Anemia Therapeutics Market Share by Region: 2022 VS 2029
Figure 14. Global Sickle Cell Anemia Therapeutics Market Share by Players in 2022
Figure 15. Global Top Sickle Cell Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Anemia Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Sickle Cell Anemia Therapeutics Revenue in 2022
Figure 17. North America Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Sickle Cell Anemia Therapeutics Market Share by Type (2018-2029)
Figure 19. North America Sickle Cell Anemia Therapeutics Market Share by Application (2018-2029)
Figure 20. North America Sickle Cell Anemia Therapeutics Market Share by Country (2018-2029)
Figure 21. United States Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Sickle Cell Anemia Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Sickle Cell Anemia Therapeutics Market Share by Type (2018-2029)
Figure 25. Europe Sickle Cell Anemia Therapeutics Market Share by Application (2018-2029)
Figure 26. Europe Sickle Cell Anemia Therapeutics Market Share by Country (2018-2029)
Figure 27. Germany Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Sickle Cell Anemia Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Sickle Cell Anemia Therapeutics Market Share by Type (2018-2029)
Figure 35. China Sickle Cell Anemia Therapeutics Market Share by Application (2018-2029)
Figure 36. Asia Sickle Cell Anemia Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Sickle Cell Anemia Therapeutics Market Share by Type (2018-2029)
Figure 38. Asia Sickle Cell Anemia Therapeutics Market Share by Application (2018-2029)
Figure 39. Asia Sickle Cell Anemia Therapeutics Market Share by Region (2018-2029)
Figure 40. Japan Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Sickle Cell Anemia Therapeutics Market Share by Country (2018-2029)
Figure 50. Brazil Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Sickle Cell Anemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Emmaus Medical Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)
Figure 57. Addmedica Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)
Figure 58. Gamida Cell Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)
Figure 59. GlycoMimetics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)
Figure 60. Pfizer Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)
Figure 61. Novartis Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)
Figure 62. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)
Figure 63. Micelle BioPharma Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)
Figure 64. Bluebird Bio Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2018-2023)
Figure 65.

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs